T. Pedersen , A. Hesselberg Løvestad , A. Ingebretsen , D.H. Skutlaberg , C.G. Ås , A. Blomfeldt
{"title":"Molecular epidemiology of a nationwide Pseudomonas aeruginosa outbreak in Norway reveals multiple distinct clusters, including high-risk clone ST244","authors":"T. Pedersen , A. Hesselberg Løvestad , A. Ingebretsen , D.H. Skutlaberg , C.G. Ås , A. Blomfeldt","doi":"10.1016/j.jhin.2025.11.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>A nationwide collection of <em>Pseudomonas aeruginosa</em> bacteraemia isolates was assembled during a wild-type <em>P. aeruginosa</em> ST3875 outbreak affecting approximately 400 patients across 40 hospitals in Norway in 2021–2022.</div></div><div><h3>Aim</h3><div>To investigate the molecular epidemiology of <em>P. aeruginosa</em> in Norway through a multi-centre retrospective study.</div></div><div><h3>Methods</h3><div>All available isolates collected over 18 months were retrieved from 20 microbiology laboratories, and underwent whole-genome sequencing at five university hospitals. Metadata, including demographics, sampling dates and locations, were collated. Phylogenetic and comparative genomic analyses were performed to identify sequence types (STs), clusters, resistance determinants, and virulence factors.</div></div><div><h3>Findings</h3><div>This study included 376 unique patients with <em>P. aeruginosa</em> bacteraemia from 33 hospitals (69% male; median age 76 years), representing >90% of the national catchment area. Incidence varied regionally (5.1–16.3 per 100,000). The ST was resolved for 362 isolates, revealing 164 distinct types. Global high-risk and epidemic clones (e.g. ST233, ST244, ST277, ST298, ST308) comprised 30% of the collection. None of the isolates carried carbapenemases or extended-spectrum β-lactamases. Aside from the ST3875 outbreak clone (<em>N</em>=56), nine unrecognized phylogenetic clusters (two to 20 cases each) spanning multiple hospitals and regions were identified, including a widespread ST244 cluster harbouring a novel genomic island with putative virulence determinants, indicating a selective advantage for dissemination.</div></div><div><h3>Conclusions</h3><div>This comprehensive genomic surveillance study uncovered multiple unexpected clusters of <em>P. aeruginosa</em> bacteraemia isolates in Norway, along with widespread presence of susceptible epidemic clones. Routine multi-level surveillance integrating sequencing with epidemiological data could enable earlier recognition of emerging high-risk clones and outbreaks, thereby strengthening infection prevention efforts.</div></div>","PeriodicalId":54806,"journal":{"name":"Journal of Hospital Infection","volume":"168 ","pages":"Pages 70-79"},"PeriodicalIF":3.1000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hospital Infection","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0195670125003603","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/19 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
A nationwide collection of Pseudomonas aeruginosa bacteraemia isolates was assembled during a wild-type P. aeruginosa ST3875 outbreak affecting approximately 400 patients across 40 hospitals in Norway in 2021–2022.
Aim
To investigate the molecular epidemiology of P. aeruginosa in Norway through a multi-centre retrospective study.
Methods
All available isolates collected over 18 months were retrieved from 20 microbiology laboratories, and underwent whole-genome sequencing at five university hospitals. Metadata, including demographics, sampling dates and locations, were collated. Phylogenetic and comparative genomic analyses were performed to identify sequence types (STs), clusters, resistance determinants, and virulence factors.
Findings
This study included 376 unique patients with P. aeruginosa bacteraemia from 33 hospitals (69% male; median age 76 years), representing >90% of the national catchment area. Incidence varied regionally (5.1–16.3 per 100,000). The ST was resolved for 362 isolates, revealing 164 distinct types. Global high-risk and epidemic clones (e.g. ST233, ST244, ST277, ST298, ST308) comprised 30% of the collection. None of the isolates carried carbapenemases or extended-spectrum β-lactamases. Aside from the ST3875 outbreak clone (N=56), nine unrecognized phylogenetic clusters (two to 20 cases each) spanning multiple hospitals and regions were identified, including a widespread ST244 cluster harbouring a novel genomic island with putative virulence determinants, indicating a selective advantage for dissemination.
Conclusions
This comprehensive genomic surveillance study uncovered multiple unexpected clusters of P. aeruginosa bacteraemia isolates in Norway, along with widespread presence of susceptible epidemic clones. Routine multi-level surveillance integrating sequencing with epidemiological data could enable earlier recognition of emerging high-risk clones and outbreaks, thereby strengthening infection prevention efforts.
期刊介绍:
The Journal of Hospital Infection is the editorially independent scientific publication of the Healthcare Infection Society. The aim of the Journal is to publish high quality research and information relating to infection prevention and control that is relevant to an international audience.
The Journal welcomes submissions that relate to all aspects of infection prevention and control in healthcare settings. This includes submissions that:
provide new insight into the epidemiology, surveillance, or prevention and control of healthcare-associated infections and antimicrobial resistance in healthcare settings;
provide new insight into cleaning, disinfection and decontamination;
provide new insight into the design of healthcare premises;
describe novel aspects of outbreaks of infection;
throw light on techniques for effective antimicrobial stewardship;
describe novel techniques (laboratory-based or point of care) for the detection of infection or antimicrobial resistance in the healthcare setting, particularly if these can be used to facilitate infection prevention and control;
improve understanding of the motivations of safe healthcare behaviour, or describe techniques for achieving behavioural and cultural change;
improve understanding of the use of IT systems in infection surveillance and prevention and control.